Intuitive Surgical, Inc.

NASDAQ Global Select
Back to all articles
Bullish +65

EndoWrist Stapler 45 from Intuitive Surgical - ad-hoc-news

🔧 Intuitive Surgical launches the EndoWrist Stapler 45, a single-patient-use robotic stapling instrument compatible with da Vinci Xi and X systems.

📈 The new accessory supports complex colorectal and thoracic procedures by enabling wristed articulation and integrated software checks for clamp and firing conditions.

💰 Recurring revenue from single-use accessories like this stapler now constitutes more than 70% of Intuitive Surgical's total sales.

📊 The 'Instruments and Accessories' segment grew double digits year-over-year in 2025, driven by high procedure volumes on the installed da Vinci base.

🏥 In the US market, the stapler is reimbursed as part of the overall procedure cost rather than billed separately to patients.

🔬 Clinical studies indicate robotic stapling can reduce conversion rates to open surgery in difficult pelvic cases compared to conventional methods.

⚙️ The device uses 45 mm reload cartridges with color-coding and software checks to reduce risks of misfires or improper tissue compression.

👨‍⚕️ Surgeons utilize the instrument for tasks like dividing bowel and mesentery, maintaining full robotic control without switching to handheld devices.

💵 Per-case instrument costs are negotiated in multi-year agreements, typically ranging from mid-three-digit to low-four-digit dollars when combining staplers and reloads.

Bullish Signals
  • The EndoWrist Stapler 45 extends the da Vinci system's dexterity to stapling tasks that previously required laparoscopic devices, enhancing clinical workflow.
  • Recurring revenue from single-use accessories now makes up over 70% of Intuitive Surgical's total sales, providing a stable financial foundation.
  • The 'Instruments and Accessories' segment achieved double-digit year-over-year growth in 2025, highlighting the strength of the consumables business model.
  • Clinical data suggests robotic stapling reduces conversion rates to open surgery in difficult pelvic cases, potentially improving patient outcomes.
Risk Factors
  • Total operating room time and cost for robotic procedures remain higher than conventional laparoscopy according to comparative datasets cited by hospital cost committees.
  • The instrument is reimbursed as part of the overall procedure cost rather than billed separately, which may limit standalone pricing power.
Full Analysis
Intuitive Surgical has introduced the EndoWrist Stapler 45, a single-patient-use robotic stapling instrument designed for its da Vinci Xi and X systems. This new accessory enables wristed articulation and integrated software confirmation for clamp and firing conditions, specifically targeting complex colorectal and thoracic procedures such as low anterior resections and sigmoid colectomies. The device is intended to extend the dexterity of Intuitive's robotic platform by allowing surgeons to perform stapling and transection tasks entirely within the robotic system, eliminating the need to switch to handheld laparoscopic devices. Clinical observations suggest this integration improves workflow and control in deep pelvic cases, though total operating room time remains higher than conventional laparoscopy. Financially, the EndoWrist Stapler 45 contributes to Intuitive Surgical's recurring revenue model, which analysts note now accounts for over 70% of total sales. The instrument is reimbursed as part of the overall procedure cost in the US, with per-case pricing negotiated through multi-year purchasing agreements that typically involve multiple reloads per surgery. Intuitive segments these instruments under 'Instruments and Accessories' in SEC filings, a category that grew double digits year-over-year in 2025. With over 9,000 da Vinci systems installed worldwide, the recurring revenue from accessories like this stapler remains a key metric for investors tracking the company's financial performance and growth trajectory.